Joseph Shulman Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

RYTM Quotes by TradingView

Joseph Shulman is Chief Technical Officer of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 8,509 shares of RYTM, which is worth approximately $490,799. The most recent transaction as insider was on Feb 19, 2025, when has been sold 1,228 shares (Common Stock) at a price of $57.22 per share, resulting in proceeds of $70,266. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.51K
Infinity% 3M change
74.81% 12M change
Total Value Held $490,799

Joseph Shulman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 19 2025
SELL
Open market or private sale
$70,266 $57.22 p/Share
1,228 Reduced 12.61%
8,509 Common Stock
Feb 16 2025
BUY
Exercise of conversion of derivative security
-
4,125 Added 29.76%
9,737 Common Stock
Feb 12 2025
SELL
Open market or private sale
$26,611 $56.74 p/Share
469 Reduced 7.71%
5,612 Common Stock
Feb 11 2025
SELL
Open market or private sale
$45,678 $57.53 p/Share
794 Reduced 99.25%
6 Common Stock
Feb 11 2025
BUY
Exercise of conversion of derivative security
-
1,562 Added 18.51%
6,875 Common Stock
Feb 09 2025
BUY
Exercise of conversion of derivative security
-
2,656 Added 33.33%
5,313 Common Stock
Feb 04 2025
SELL
Open market or private sale
$76,129 $59.43 p/Share
1,281 Reduced 32.53%
2,657 Common Stock
Feb 01 2025
BUY
Exercise of conversion of derivative security
-
3,938 Added 50.0%
3,938 Common Stock
Nov 11 2024
SELL
Open market or private sale
$888,100 $66.87 p/Share
13,281 Reduced 100.0%
0 Common Stock
Nov 11 2024
BUY
Exercise of conversion of derivative security
$187,129 $14.09 p/Share
13,281 Added 50.0%
13,281 Common Stock
Jul 16 2024
SELL
Open market or private sale
$554,804 $53.0 p/Share
10,468 Reduced 99.71%
30 Common Stock
Jul 16 2024
BUY
Exercise of conversion of derivative security
$286,299 $27.35 p/Share
10,468 Added 49.93%
10,498 Common Stock
Jul 12 2024
SELL
Open market or private sale
$265,703 $50.01 p/Share
5,313 Reduced 99.44%
30 Common Stock
Jul 12 2024
BUY
Exercise of conversion of derivative security
$113,591 $21.38 p/Share
5,313 Added 49.86%
5,343 Common Stock
May 09 2024
SELL
Open market or private sale
$154,340 $38.74 p/Share
3,984 Reduced 99.25%
30 Common Stock
May 09 2024
BUY
Exercise of conversion of derivative security
$27,091 $6.8 p/Share
3,984 Added 49.81%
4,014 Common Stock
Mar 21 2024
SELL
Open market or private sale
$735,599 $40.34 p/Share
18,235 Reduced 99.84%
30 Common Stock
Mar 19 2024
SELL
Open market or private sale
$608,498 $39.22 p/Share
15,515 Reduced 45.93%
18,265 Common Stock
Feb 16 2024
BUY
Grant, award, or other acquisition
-
33,750 Added 49.98%
33,780 Common Stock
Feb 14 2024
SELL
Open market or private sale
$54,460 $50.01 p/Share
1,089 Reduced 97.32%
30 Common Stock
Feb 13 2024
SELL
Open market or private sale
$93,250 $50.0 p/Share
1,865 Reduced 62.5%
1,119 Common Stock
Feb 13 2024
SELL
Open market or private sale
$23,574 $49.84 p/Share
473 Reduced 13.68%
2,984 Common Stock
Feb 12 2024
SELL
Open market or private sale
$40,641 $51.38 p/Share
791 Reduced 18.62%
3,457 Common Stock
Feb 11 2024
BUY
Exercise of conversion of derivative security
-
1,562 Added 26.88%
4,248 Common Stock
Feb 09 2024
SELL
Open market or private sale
$3,603,054 $50.2 p/Share
71,774 Reduced 96.39%
2,686 Common Stock
JS

Joseph Shulman

Chief Technical Officer
Boston, MA

Track Institutional and Insider Activities on RYTM

Follow RHYTHM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RYTM